Close Menu

PerkinElmer

Richard Rava joined Artemis Health, Joseph Blanchard was named CEO of Aushon Biosystems, Alan Carter was named VP of global development for Agendia, and more.

Millipore is betting that the buy, which is expected to close in the next several weeks, will provide its customers a powerful cell biology/protein expression-analysis tool for the benchtop.

Lai Named SVP of R&D at Gen-Probe, Jorge Leon Joins ParagonDx SAB, Strategic Diagnostics Hires Two Execs, and More.

It was not immediately clear whether PerkinElmer would divest all of its proteomics assets or retain a portion of them, though it described them as “discontinued operations” during its fourth-quarter earnings statement.

BioArray Briefs: 2009.02.03

Premium

Cancer Research UK, Fluidigm, Fox Chase Cancer Center, BioDiscovery, Mondobiotech, 23andMe

While Helicos and Rosetta Genomics rose, shares of Cepheid were hit by its forecast of lower revenues. But, overall, the GWDN Index managed to gain ground while the broader market fell.

People in the News: Feb 3, 2009

Premium

Frank Witney, Allen Bombard

Paired Ends: Feb 3, 2009

Premium

Monette Greenway, Robert Laffer

Pages

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.